Roche bid to retool arthritis drug for COVID-19 fails

The COVACTA trial did not meet its primary end-point of improved clinical status in patients with COVID-19 associated pneumonia, or the key secondary end-point of reduced patient mortality, Roche said

from Livemint - Science https://ift.tt/3hR7NN3